Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline. | ...

By the time a doctor prescribes antibiotics, the microbial enemy has already slipped past our defenses. But the war against ...

Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

A study shows continued increase in antibiotic resistance is not inevitable and offers new insights to help monitor drug ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

The novel antibiotic class could be active against the vast majority of multidrug-resistant Enterobacterales infections.

In seeking new antibiotic sources, researchers have turned to an unlikely source: a whiffy frog known as Odorrana andersonii.

Researchers created safe synthetic antibiotics from frog molecules. These may help fight superbugs in the future.